Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation

Francine Foss, MD A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options.  In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies.  We also discuss the critical role of clinical trials in shaping the future of CTCL care.   DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Cutaneous T-cell Lymphoma Fact Sheet Recent LLS T-cell lymphoma webcast LLS Clinical Trial Support Center ClinicalTrials.gov Stem cell transplantation CAR T-cell therapy Bispecific antibodies – Immunotherapy fact sheet Additional LLS Support Resources:  Free Nutrition Consultations Information Specialists  Financial support Free telephone/web patient programs  Free booklets  Young Adult Resources Online chats  Support groups  Caregiver support  Caregiver Workbook Advocacy and Public Policy Survivorship Workbook LLS Community  Mental Health Resources Supported by Kyowa Kirin, Inc.The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.